OR5BH1P

Across TCGA pan-cancer cohorts, OR5BH1P RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated OR5BH1P data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher OR5BH1P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR5BH1P expression acts as an unfavorable survival marker, although some lineages such as UCS and GBM show a favorable association.

LIHC, UCS, and UVM are the cancer types where OR5BH1P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	DFS	Tertile	All	0.205	0.452	<.001	99	view →
UCS	DFS	Median	II,III,IV	0.531	0.179	<.001	66	view →
UVM	DFS	Tertile	All	0.200	0.752	.004	45	view →
READ	DFS	Tertile	All	0.195	0.628	.001	45	view →
DLBC	OS	Tertile	II,III,IV	0.279	1.000	.003	42	view →
ACC	DFS	Tertile	III,IV	0.046	0.670	.001	36	view →
COAD	DFS	Tertile	IV	0.035	0.501	<.001	33	view →
BLCA	OS	Tertile	IV	0.462	0.637	.007	31	view →
GBM	DFS	Tertile	All	0.417	0.184	.011	24	view →
KIRP	DFS	Tertile	II,III,IV	0.122	0.626	.032	18	view →
ESCA	OS	Median	All	1.000	0.659	.020	15	view →
HNSC	DFS	Tertile	IV	0.480	0.315	.008	14	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

OR5BH1P–LIHC (DFS)

Open the LIHC breakdown →